A 100-bed comprehensive oncology hospital is coming up in Nagpur
Nagpur, the third largest city in the state of Maharashtra, is slated to witness the commissioning of a comprehensive oncology hospital in the month of December. The 100-bed hospital, located at MIDC, Hingna Road, is a joint venture between American Oncology Institute (AOI) and the Cure All Group, promoted by the Nangia Family- a prominent business family of Nagpur that owns a super specialty and radiation therapy centre in the same city.
The Greenfield hospital, built ground up, is known as ‘American Oncology Institute at Nangia Specialty Hospital’. Says Dr Lloyd Nazareth, Group CEO, AOI, “The hospital will serve almost 25 million patients from the Vidharbha region of Maharashtra, eastern Madhya Pradesh and southern Chhattisgarh regions.” The hospital will provide a comprehensive range of cancer services with surgical oncology, medical oncology, haemato-oncology, BMT and full range of cancer diagnostics. The hospital would also offer oncology-related specialties like surgical and medical GI, urology and ENT. The investment for the project is Rs 90 crore project, of which the Nangias are investing on the infrastructure while AOI is investing on the equipment. "AOI would fully operate the facility," says Dr Lloyd.
Esta historia es de la edición November 2017 de Healthcare Radius.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición November 2017 de Healthcare Radius.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
KIMSHEALTH launches electrophysiology lab with 3D mapping
'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.
Molbio boosts Goa's healthcare system with CSR initiatives
The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies
USV introduces affordable heart failure medication
This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.
City Imaging & Clinical Labs to expand services to 50 hospitals
The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.
Oncare raises $1 million in seed funding, to set up 10 units
Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.
Nutrabay forays into Ayurvedic supplements market with Shilajit
Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?
